金年会·(jinnianhui)金字招牌诚信至上-Gold Annual Meeting

<金年会·(jinnianhui)金字招牌诚信至上-Gold Annual Meetingrz id='uhfjnz'>
  • <金年会·(jinnianhui)金字招牌诚信至上-Gold Annual Meeting class='ezzxqb'>
    <金年会·(jinnianhui)金字招牌诚信至上-Gold Annual Meetingcq class='wwwjbi'>

    欢迎来到上海金年会·(jinnianhui)金字招牌诚信至上-Gold Annual Meeting!

    021-54888888/15800441009

    品质保证 · 金年会·(jinnianhui)金字招牌诚信至上-Gold Annual Meeting试剂

    当前位置: 首页 > 科研产品 > 科研抗体 > 其他抗体 > LATS1抗原(重组蛋白)

    产品中心

    • LATS1抗原(重组蛋白)

      规格:
      数量:

      购买数量

      价格:
      • 品牌 : 金年会·(jinnianhui)金字招牌诚信至上-Gold Annual Meeting生物
      • 目录号 : TW19205
      • 应用 : 仅供科研使用
      • 保存条件 : 低温保存
      • 货期 : 现货
      • 商品库存:60
    • 商品详情
    • 参考文献
    • 说明书下载
    • 商品评论0
    • 相关产品

    中文名称: LATS1抗原(重组蛋白)

    英文名称: LATS1 Antigen (Recombinant Protein)

    别     名:  wts; WARTS

    储     存:  冷冻(-20℃)

    相关类别: 抗原

    概     述

    Full length fusion protein

    技术规格

    Full name:

    large tumor suppressor kinase 1

    Synonyms:

    wts; WARTS

    Swissprot:

    O95835

    Gene Accession:

    BC015665

    Purity:

    >85%, as determined by Coomassie blue stained SDS-PAGE

    Expression system:

    Escherichia coli

    Tags:

    His tag C-Terminus, GST tag N-Terminus

    Background:

    The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments.



    【网站地图】【sitemap】
    【网站地图】【sitemap】